International Clinical Trial: Efficacy and Safety of Different Dual Regimens Based on Tegoprazan for the Eradication of Helicobacter pylori Infection in Treatment-naive Patients: A Prospective, Randomized, Open-label, Multicenter Trial

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119367) titled 'Efficacy and Safety of Different Dual Regimens Based on Tegoprazan for the Eradication of Helicobacter pylori Infection in Treatment-naive Patients: A Prospective, Randomized, Open-label, Multicenter Trial' on Feb. 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Third Hospital

Condition: Helicobacter pylori infection

Intervention: Tegoprazan-Amoxicillin group(TA group):Tegoprazan-Amoxicillin dual eradication regimen Tegoprazan-tetracycline group(TT group):Tegoprazan-tetracycline dual eradication regimen

Recruitment Status: Not Recruiting

Phase: N/A

Date ...